title: Enhancing anti-melanoma immunity by electrochemotherapy and in vivo dendritic-cell activation.
abstract: Combining electrochemotherapy with dendritic cell-based immunotherapy is a promising strategy against human metastatic melanoma that deserves to be clinically assessed. While electrochemotherapy induces a rapid regression of metastases, immunotherapy generates systemic anticancer immunity, contributes to eradicate the tumor and maintains an immunological memory to control relapse.
authors.affiliation: Plastic Surgery Unit; Regional Melanoma Referral Center; Tuscan Tumor Institute (ITT); Santa Maria Annunziata Hospital; Florence, Italy.
authors.forename: Gianni
authors.initials: G
authors.lastname: Gerlini
authors.forename: Paola
authors.initials: P
authors.lastname: Di Gennaro
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Borgognoni